Creative Bioarray Introduces New RNA Samples to Global Biological Researchers

Creative Bioarray, a well-recognized service provider propelled by integrity, expertise and the desire to contribute to tomorrow’s bioscience discoveries, has introduced RNA Sample to academic, pharmaceutical, and biotechnology organizations that are committed to biological research. 

 

Creative Bioarray provides an extensive range of high quality RNA samples for biological researchers, such as Skin Fibroblast Total RNA, Bone Marrow Stromal Cell Total RNA (Diabetes Type II), and Dental Pulp Total RNA (RA). These samples are ideal for Northern blotting, ribonuclease protection assay, SI nuclease assay, RT-PCR/Q-PCR analysis, rapid amplification of cDNA ends (RACE) and purification of mRNA for library construction.   

 

These newly released RNA samples are isolated from human normal, fetal, diseased, and tumor tissues, mouse, rat, monkey, and plant tissues that might difficult to obtain because of anatomical complexity, size or high RNase tissue content. And all the RNA samples are treated with RNase-free DNase and genomic DNA polysaccharides to remove residual DNA or other contaminations, precisely quantified, and stored at -80oC. The integrity of each RNA sample as indicated by intact ribosomal RNA is verified by denatured agarose gel electrophoresis. 

 

“Creative Bioarray has the ability to do custom tissue collections and total RNA preparation to meet researchers’ specific research objective,” said Sherry W. Corchado, the Executive Director of Marketing at Creative Bioarray. “Additionally, we also value the chances in providing help for their biomedical research, and we look forward to releasing additional products and are delighted to make them available to our customers to improve their RNA sequencing analyses.”

 

“We’re excited about the opportunities that Creative Bioarray’s RNA Samples will bring to global researchers undertaking bioscience research. We recognized a consumer need to enhance the tools available for miRNA research, and our new tissue samples provide a combination of performance, multiplexing, throughput, cost and ease of use.” added by Dr. Hannah Cole, the senior scientific officer of R&D department of Creative Bioarray.